AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM for integrating ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...

AGC Biologics is partnering with ATUM to integrate technology designed to increase yields and shorten the path to clinical trials.

Cell line engineering and development play a critical role in the production of gene therapies by creating the potential for a stable and reproducible process, which can significantly reduce the cost ...

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already available, and adeno-associated virus (AAV) has become a popular choice for ...

One of the hallmarks of cancer cells is their ability to evade apoptosis, or programmed cell death, through changes in ...

Induced pluripotent stem cells (iPSC), a continuing muse in cell therapy research, could potentially be used to improve flaws associated with conventional CAR T therapy. What if an effective cancer ...

Bristol Myers Squibb BMY recently obtained FDA approval for the label expansion of Breyanzi (lisocabtagene maraleucel) for ...

Genmab A/S(Nasdaq:GMAB)today announced updated results from two ongoing clinical trials evaluating the efficacy and safety of epcoritamab-bysp, a T-cellengaging antibody administered subcutaneously, ...

Second-line treatment of small-cell lung cancer (SCLC) may include chemotherapy, immunotherapy, and palliative care. While some people respond to second-line treatments, the outlook for people with ...